Breast Cancer Market Research Report – Segmentation by Cancer Type (Hormone Therapy, HER 2+, Triple-Negative Breast Cancer, Others); By Therapy (Targeted therapy, Hormonal therapy, Chemotherapy, Immunotherapy); By Distribution Channel (Hospitals, Clinics, Pharmacy, Online Pharmacy); Region – Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-16098
Format:
Region: Global
Chapter 1. GLOBAL BREAST CANCER MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. GLOBAL BREAST CANCER MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.4. Attractive Investment Propositions
2.5. COVID-19 Impact Analysis
Chapter 3. GLOBAL BREAST CANCER MARKET – Competition Scenario
3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis
Chapter 4. GLOBAL BREAST CANCER MARKET - Entry Scenario
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.5. PESTLE Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL BREAST CANCER MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. GLOBAL BREAST CANCER MARKET – By Cancer Type
6.1. Hormone Therapy
6.2. HER 2+
6.3. Triple-Negative Breast Cancer
6.4. Others
Chapter 7. GLOBAL BREAST CANCER MARKET – By Theraphy
7.1. Targeted therapy
7.2. Hormonal therapy
7.3. Chemotherapy
7.4. Immunotherapy
Chapter 8. GLOBAL BREAST CANCER MARKET – By Distribution Channel
8.1. Hospitals
8.2. Clinics
8.3. Pharmacy
8.4. Online Pharmacy
Chapter 9. GLOBAL BREAST CANCER MARKET, By Geography – Market Size, Forecast, Trends & Insights
9.1. North America
9.1.1. By Country
9.1.1.1. U.S.A.
9.1.1.2. Canada
9.1.1.3. Mexico
9.1.2. By Cancer Type
9.1.3. By Theraphy
9.1.4. By Distribution Channel
9.1.5. Countries & Segments - Market Attractiveness Analysis
9.2. Europe
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Germany
9.2.1.3. France
9.2.1.4. Italy
9.2.1.5. Spain
9.2.1.6. Rest of Europe
9.2.2. By Cancer Type
9.2.3. By Theraphy
9.2.4. By Distribution Channel
9.2.5. Countries & Segments - Market Attractiveness Analysis
9.3. Asia Pacific
9.3.2. By Country
9.3.2.2. China
9.3.2.2. Japan
9.3.2.3. South Korea
9.3.2.4. India
9.3.2.5. Australia & New Zealand
9.3.2.6. Rest of Asia-Pacific
9.3.2. By Cancer Type
9.3.3. By Theraphy
9.3.4. By Distribution Channel
9.3.5. Countries & Segments - Market Attractiveness Analysis
9.4. South America
9.4.3. By Country
9.4.3.3. Brazil
9.4.3.2. Argentina
9.4.3.3. Colombia
9.4.3.4. Chile
9.4.3.5. Rest South America
9.4.2. By Cancer Type
9.4.3. By Theraphy
9.4.4. By Distribution Channel
9.4.5. Countries & Segments - Market Attractiveness Analysis
9.5. Middle East & Africa
9.5.4. By Country
9.5.4.4. United Arab Emirates (UAE)
9.5.4.2. Saudi Arabia
9.5.4.3. Qatar
9.5.4.4. Israel
9.5.4.5. South Africa
9.5.4.6. Nigeria
9.5.4.7. Kenya
9.5.4.8. Egypt
9.5.4.9. Rest of MEA
9.5.2. By Cancer Type
9.5.3. By Theraphy
9.5.4. By Distribution Channel
9.5.5. Countries & Segments - Market Attractiveness Analysis
Chapter 10. GLOBAL BREAST CANCER MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1. Bristol Myers Squibb Co.
10.2. Kyowa Kirin,
10.3. Eisai Co. Ltd,
10.4. Sanofi,
10.5. Pfizer Inc,
10.6. Merck & Co,
10.7. Novartis AG,
10.8. Eli Lilly and Company,
10.9. Genentech, Mylan Laboratories
Download Sample
Choose License Type
2500
4250
5250
6900
Frequently Asked Questions
The key trends in the breast cancer drugs Market are an increase in the aging population of women, a rise in the prevalence of breast cancer, the launch of innovative medications, a boost in healthcare expenditure, and higher government support
An increasing number of breast cancers among the growing population and growing healthcare awareness are some of the drivers of the breast cancer market.
Based on Treatment Type, the Breast Cancer Market is segmented into Targeted Therapy, Chemotherapy, Immunotherapy, and Hormonal therapy.
North America is the most dominant region for the Breast Cancer Market.
Bristol Myers Squibb, Kyowa Kirin, Eisai Co. Ltd, Sanofi, Pfizer Inc, Merck & Co, Novartis AG, Eli Lilly and Company, Genentech, Mylan Laboratories, Celltrion, Fresenius Kabi, Baxter Healthcare Corporation, Halozyme Inc, GlaxoSmithKline, AstraZeneca
